Intraocular lenses in age-related macular degeneration

被引:21
作者
Grzybowski, Andrzej [1 ,2 ,3 ]
Wasinska-Borowiec, Weronika [4 ]
Alio, Jorge L. [5 ,6 ]
Amat-Peral, Pedro [5 ,6 ]
Tabernero, Juan [7 ]
机构
[1] Univ Warmia & Mazury, Chair Ophthalmol, Olsztyn, Poland
[2] Poznan City Hosp, Dept Ophthalmol, Poznan, Poland
[3] Ul Szwajcarska 3, PL-61285 Poznan, Poland
[4] Univ Warmia & Mazury, Dept Ophthalmol, Olsztyn, Poland
[5] Vissum Corp, Alicante, Spain
[6] Univ Miguel Hernandez, Div Ophthalmol, Alicante, Spain
[7] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England
关键词
Implantable miniature telescope; IOL-VIP system; Lipshitz macular implant; Fresnel prism intraocular lens; iolAMD; Scharioth macula lens; IMPLANTABLE MINIATURE TELESCOPE; SAFETY OUTCOMES; VISUAL-ACUITY; MAGNIFICATION; EFFICACY; DISEASE; SYSTEM;
D O I
10.1007/s00417-017-3740-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The aim of this work is to review the lenses, assessing their advantages and disadvantages. We describe a total of seven types of intraocular lenses (IOLs) recommended for age-related macular degeneration (AMD). We used the PubMed web platform to search for implantable devices in various stages of AMD. We searched for both prospective and retrospective studies and also case reports. Clinical results in AMD patients have been described for a total of seven types of IOLs recommended for AMD: an implantable miniature telescope (IMT), IOL-VIP System, Lipshitz macular implant (LMI), sulcus-implanted Lipshitz macular implant, LMI-SI, Fresnel Prism Intraocular Lens, iolAMD and Scharioth Macula Lens. We conclude that to objectively ascertain the effectiveness and safety of these lenses, further independent clinical studies with longer follow-up data are necessary prior to the general use of these optical devices.
引用
收藏
页码:1687 / 1696
页数:10
相关论文
共 50 条
  • [31] Current Management of Age-Related Macular Degeneration
    Ung, Cindy
    Lains, Ines
    Miller, Joan W.
    Kim, Ivana K.
    AGE-RELATED MACULAR DEGENERATION: FROM CLINIC TO GENES AND BACK TO PATIENT MANAGEMENT, 2021, 1256 : 295 - 314
  • [32] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [33] Global prevalence of age-related macular degeneration
    Jonas, Jost B.
    LANCET GLOBAL HEALTH, 2014, 2 (02): : E65 - E66
  • [34] Age-related macular degeneration in Onitsha, Nigeria
    Nwosu, S. N. N.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2011, 14 (03) : 327 - 331
  • [35] Fear of falling in age-related macular degeneration
    van Landingham, Suzanne W.
    Massof, Robert W.
    Chan, Emilie
    Friedman, David S.
    Ramulu, Pradeep Y.
    BMC OPHTHALMOLOGY, 2014, 14
  • [36] Fear of falling in age-related macular degeneration
    Suzanne W van Landingham
    Robert W Massof
    Emilie Chan
    David S Friedman
    Pradeep Y Ramulu
    BMC Ophthalmology, 14
  • [37] PegaptanibIn Exudative Age-Related Macular Degeneration
    M. Asif A. Siddiqui
    Gillian M. Keating
    Drugs, 2005, 65 : 1571 - 1577
  • [38] Glaucoma and age-related macular degeneration intricacy
    Valtot, F.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2008, 31 (06): : 55 - 60
  • [39] Object crowding in age-related macular degeneration
    Wallace, Julian M.
    Chung, Susana T. L.
    Tjan, Bosco S.
    JOURNAL OF VISION, 2017, 17 (01):
  • [40] Radiotherapy for neovascular age-related macular degeneration
    Evans, Jennifer R.
    Igwe, Chinedu
    Jackson, Timothy L.
    Chong, Victor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (08):